Adjuvant Therapy in Locally Advanced Pancreatic Cancer

preview_player
Показать описание
John L. Marshall, MD; Tanios S. Bekaii-Saab, MD; Eileen M. O’Reilly, MD; Kabir Mody, MD; and George P. Kim, MD, review the role of adjuvant modified FOLFIRINOX versus gemcitabine in patients with resected locally advanced pancreatic adenocarcinoma and comment on dose modifications to avoid toxicities.
Рекомендации по теме